Abstract
Subcutaneous bortezomib is highly effective for pure red cell aplasia after <scp>ABO</scp>‐incompatible haematopoietic stem cell transplantation
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
